Kennedy Disease - 25 Studies Found Recruiting : Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies : Advanced Epithelial Ovarian Recurrent Epithelial Ovarian F : 2013-10-25 : Drug: Enzalutamide All enrolled patients will be treated with enzalutamide 160mg by mouth QD. Study drug Recruiting : A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer : Prostate Cancer : 2015-07-06 : Drug: LY2452473 LY2452473 is a Not yet recruiting : Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer : Castration-Resistant Prostatic Cancer Metastatic Prostate Carcinoma Biological: GnRH agonist/antagonist Completed : Genetic Polymorphism of the Androgen Receptor-Gene and Sexual Function in Middle Aged Women : Libido Receptors, Androgen Polymorphism, Genetic : 2013-10-30 Recruiting : Study of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy : Liver Motor Neuron Disease : 2014-04-25 Recruiting : Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers : Salivary Cancer : 2016-04-21 : Drug: enzalutamide oral Withdrawn : STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling : Adenocarcinoma of the Prostate : 2011-04-21 : Drug: STA9090 200 mg/m^2 IV ev Recruiting : Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR) : Metastatic Breast Cancer : 2013-11-08 : Drug: Orteronel Other Name: Tak-700 Active, not recruiting : The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer : Prostate Cancer : 2013-02-08 : Drug: ARN-509 Drug: LHRH Agonist Recruiting : Phase II Trial of Enzalutamide for CRPC With Correlative Assessment of Androgen Receptor Signaling : Prostate Cancer : 2013-09-04 : Drug: Enzalutamide Administration: 160 mg orally once dail <<< Previous | Next >>>